Inventor
IN JONG KIM
Inventor
US
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds36%
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07BGeneral methods of organic chemistry2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C07KPeptides2%
PatentTitleYear
12,509,470Antiviral heterocyclic compounds202512,358,921Antiviral heterocyclic compounds202512,297,209Benzodiazepine derivatives as RSV inhibitors202512,268,694Combination pharmaceutical agents as RSV inhibitors202512,162,857Antiviral compounds202412,006,326Antiviral heterocyclic compounds202411,952,389Benzodiazepine derivatives as RSV inhibitors202411,945,830Antiviral heterocyclic compounds202411,945,824Heterocyclic compounds as anti-viral agents202411,912,695Benzodiazepine derivatives as RSV inhibitors202411,572,367Antiviral heterocyclic compounds202311,534,439Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors202211,505,558Antiviral heterocyclic compounds202211,390,631Benzodiazepine derivatives as RSV inhibitors202211,254,664Benzodiazepine derivatives as RSV inhibitors202211,179,400Heterocyclic compounds as RSV inhibitors2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to ENANTA PHARM INC (16)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ENANTA PHARM INC | 16 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 16 | 2021–2025 |